Taiwan pharma group quashes damages award in Germany
The German Supreme Court has set aside a €140 million damages award against a Taiwanese pharmaceuticals company after finding the ICC tribunal violated its right to be heard – in a fight over a blood cancer drug that has spawned a second ICC case worth US$5 billion and a criminal complaint.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.